tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinom, pulmonar non-celulă mică - agenți antineoplazici - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
allergodil1 mg/ml
meda manufacturing gmbh - germania - azelastinum - spray nazal, sol. - 1mg/ml - decongestionante si alte medicamente nazale de uz topic medicamente antialergice exclusiv corticosteroizi
allergodil1 mg/ml
madaus gmbh - germania - azelastinum - spray naz.,sol. - 1mg/ml - decongestionante si alte medicamente nazale de uz topic medicamente antialergice exclusiv corticosteroizi
vesomni comprimate filmate cu eliberare prelungita 0,4 mg + 6 mg
astellas pharma europe b.v. - tamsulosinum + solifenacinum - comprimate filmate cu eliberare prelungita - 0,4 mg + 6 mg
ganfort
allergan pharmaceuticals ireland - irlanda - combinatii (bimatoprostum + timololum) - pic. oft., sol. - 0,3mg/ml+5mg/ml - antiglaucomatoase si miotice agenti betablocanti
lumigan 0,1mg/ml
allergan pharmaceuticals ireland - irlanda - bimatoprostum - pic. oft., sol. - 0,1mg/ml - antiglaucomatoase si miotice analogi de prostaglandine
xydalba 500 mg
allergan pharmaceuticals international ltd. - irlanda - dalbavancinum - pulb. pt. conc. pt. sol. perf. - 500mg - alte antibacteriene antibacteriene glicopeptidice
actrapid hm 100 ui/ml soluţie injectabilă
novo nordisk a/s - insulinum umane - soluţie injectabilă - 100 ui/ml